Arjuna Capital Biogen Inc. Transaction History

Arjuna Capital

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $29,382 - $33,163	116 Added 3.17%	3,772 $969,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $56,151 - $64,884	204 Added 5.91%	3,656 $1.04 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $885,645 - $1.01 Million	3,452 New	3,452 $959,000
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $659,637 - $992,918	-2,792 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $1.15 Million - $1.33 Million	-4,354 Reduced 60.93%	2,792 $792,000
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $21,986 - $29,116	85 Added 1.2%	7,146 $1.91 Million
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $1.3 Million - $1.64 Million	4,820 Added 215.08%	7,061 $2.23 Million
Q4 2019 Jan 30, 2020	BUY	$220.06 - $304.07 $493,154 - $681,420	2,241 New	2,241 $665,000
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $612,915 - $675,607	-2,795 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $605,704 - $947,393	2,795 New	2,795 $661,000

993

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

Stay updated on Arjuna Capital with notifications on news.